[Preliminary study on the effect of a nicergoline composition (F.I. 6714) on cerebral blood flow].
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D001921:Brain / Q000098:blood supply*; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004873:Ergolines / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D009539:Nicotinic Acids / Q000494:pharmacology / Q000627:therapeutic use; D012039:Regional Blood Flow / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D004873:Ergolines; D009539:Nicotinic Acids
Osservazioni preliminari sull'azione del composto nicergolina (F.I. 6714) sul flusso cerebrale